EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tetrastigma hemsleyanum Diels et Gilg Flavonoids Against Acute Lung Injury Via Block NLRP3 Inflammation

Lianghui Zhan iD, Lingling Li iD, Xiaojun Wu, Xuechun Jiang, Jie Zhou iD, Sheng Zhu, Changcheng Shu, Jinbao Pu iD, Weiqing Liang iD

Mediators of Inflammation · 2026-01 · 2026 (1)

DOI: 10.1155/mi/2279402 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mediators of Inflammation, online erschienen am 08.03.2026. Verfasst von Lianghui Zhan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang, 310014, China, zjtongde.com. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Acute Lung Injury, Flavonoids, Inflammation. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tetrastigma hemsleyanum Diels et Gilg (Sanyeqing [SYQ]), a traditional anti‐inflammatory herb, has been used to treat respiratory disorders.

Aims

To elucidate the mechanism of SYQ flavonoids in mitigating acute lung injury (ALI). Materials and methods An integrated approach combined network pharmacology, HPLC, lipopolysaccharide (LPS)‐induced ALI mouse models, and NOD‐like receptor thermal protein domain associated protein 3 (NLRP3)‐activated cellular assays (LPS + nigericin). NLRP3 knockdown (siRNA) and molecular docking were employed for mechanistic validation.

Results

Network pharmacology and HPLC identified procyanidin B1 and catechin as core active compounds targeting the NLRP3 inflammasome pathway. Animal experiments demonstrated that SYQ flavonoids can significantly alleviate pathological damage to lung tissue, reduce pulmonary edema, and inhibit the expression of pro‐inflammatory factors, thereby exerting a protective effect against ALI. Furthermore, SYQ flavonoids exhibited protective effects against ALI by downregulating the expressions of interleukin (IL)‐1β, IL‐18, NLRP3, ASC, and caspase‐1. Notably, when NLRP3 was knocked down using siRNA technology, it had no significant effect on the levels of IL‐1β and IL‐18, indicating that their therapeutic effects are mediated through the NLRP3 pathway. Finally, molecular docking confirmed that both catechin and procyanidin B1 exhibit strong binding affinities with NLRP3, providing a molecular basis for their targeted inhibition of the NLRP3 inflammasome.

Conclusion

SYQ flavonoids alleviate ALI by specifically inhibiting the NLRP3 inflammasome, providing a mechanistic basis for its traditional use in lung inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinAcute Lung InjuryFlavonoidsInflammationVitaceaeAnimalsMiceMolecular Docking SimulationMaleLipopolysaccharidesCatechinInflammasomesBiflavonoidsProanthocyanidinsMice, Inbred C57BLInterleukin-1beta

Stichwörter der Autor:innen

NLRP3 inflammasomeSanyeqingacute lung injurymolecular dockingnetwork pharmacology

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinFlavonoidsLipopolysaccharidesCatechinNlrp3 protein, mouseInflammasomesBiflavonoidsProanthocyanidinsprocyanidin B1Interleukin-1beta

Autor:innen und Institutionen

  • Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang, 310014, China, zjtongde.com.
  • Center for Medicinal Resources Research, Zhejiang Academy of Traditional Chinese Medicine, Hangzhou, Zhejiang, 310014, China, zcmu.edu.cn.
  • Zhejiang Key Discipline in Traditional Chinese Medicine for Pharmaceutical Botony, Hangzhou, Zhejiang, 310014, China.
  • Zhejiang Engineering Research Center for Quality Assessment and Development of Dao-di Herbs, Hangzhou, Zhejiang, 310014, China.
  • College of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310014, China, zcmu.edu.cn.
  • Zhejiang Guangsheng New Energy Co., Ltd., Quzhou, Zhejiang, 324000, China.

ORCID-Profile: Lianghui Zhan, Lingling Li, Jie Zhou, Jinbao Pu, Weiqing Liang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhan, L., Li, L., Wu, X., Jiang, X., Zhou, J., Zhu, S., Shu, C., Pu, J., & Liang, W. (2026). Tetrastigma hemsleyanum Diels et Gilg Flavonoids Against Acute Lung Injury Via Block NLRP3 Inflammation. Mediators of Inflammation, 2026(1). https://doi.org/10.1155/mi/2279402

Vancouver

Zhan L, Li L, Wu X, Jiang X, Zhou J, Zhu S, et al. Tetrastigma hemsleyanum Diels et Gilg Flavonoids Against Acute Lung Injury Via Block NLRP3 Inflammation. Mediators of Inflammation. 2026;2026(1). doi:10.1155/mi/2279402

BibTeX
@article{Zhan2026,
  author = {Zhan, Lianghui and Li, Lingling and Wu, Xiaojun and Jiang, Xuechun and Zhou, Jie and Zhu, Sheng and Shu, Changcheng and Pu, Jinbao and Liang, Weiqing},
  title = {Tetrastigma hemsleyanum Diels et Gilg Flavonoids Against Acute Lung Injury Via Block NLRP3 Inflammation},
  journal = {Mediators of Inflammation},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/mi/2279402}
}
Kostenlos starten →